RESEARCH-USE BIOSIMILAR ANTIBODY
Ansuvimab
Monoclonal antibody · IgG1
Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody that exhibits antiviral activity against Zaire ebolavirus. Ansuvimab binds to the glycoprotein on Zaire ebolavirus to block its entry into host cells.
TARGETZaire Ebolavirus GP1
YMonoclonal antibody
CATALOGSC-BS-765
CATALOG NUMBERSC-BS-765
MOLECULAR WEIGHTApprox. 143.94 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody that exhibits antiviral activity against Zaire ebolavirus. Ansuvimab binds to the glycoprotein on Zaire ebolavirus to block its entry into host cells.
Ansuvimab is a recombinant research-use antibody directed against Zaire Ebolavirus GP1.